Between the lines: Trade-offs and timing in aging interventions
01/11/23 • 6 min
Gordon and show editor Stella revisit key concepts from the conversation with Linda Partridge, such as what we can learn from evolutionary biology and how to harness biological processes like autophagy. Looking ahead, they anticipate discussing human clinical trials in the next episode with Nir Barzilai.
Gordon and show editor Stella revisit key concepts from the conversation with Linda Partridge, such as what we can learn from evolutionary biology and how to harness biological processes like autophagy. Looking ahead, they anticipate discussing human clinical trials in the next episode with Nir Barzilai.
Previous Episode
Linda Partridge: The Nature of Aging
Aging appears to progress similarly across species, from worms and flies to mice and humans, and involves pathways related to early development. Guest Linda Partridge talks with Gordon while visiting the Buck Institute to discuss the evolutionary trade offs of aging mechanisms, the role of nutrient-sensing pathways, and how we might get the most benefit from preventative interventions in midlife.
Next Episode
Nir Barzilai: The Secrets of Centenarians
Is aging truly inevitable? Can we study the genetics of long-lived people to learn how to delay or reverse aging? In this episode, Gordon talks with Dr. Nir Barzilai about his research on centenarians, insulin signaling pathways, and moving aging interventions out of the lab and into the clinic.
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/were-not-getting-any-younger-yet-311283/between-the-lines-trade-offs-and-timing-in-aging-interventions-44936863"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to between the lines: trade-offs and timing in aging interventions on goodpods" style="width: 225px" /> </a>
Copy